MedTrace Logo

Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems

NCT02475200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-06-09

No results posted yet for this study

Summary

The Phoenix Post-Approval Registry is a prospective, multi-center, single arm registry sponsored by Volcano Corporation to evaluate the short and long term performance and clinical outcomes of the Phoenix Atherectomy System.

Conditions

  • Peripheral Arterial Disease
  • Claudication
  • Critical Limb Ischemia

Interventions

DEVICE

Atherectomy

Selectively cut and remove atheromatous plaque in the lower extremities. Debulking and removal of atherosclerotic burden plaque with Phoenix Atherectomy System.

Sponsors & Collaborators

  • Volcano Corporation

    lead INDUSTRY

Principal Investigators

  • Bradley S Matsubara, MD · Volcano Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-14
Primary Completion
2018-04-08
Completion
2020-05-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02475200 on ClinicalTrials.gov